is tirzepatide a glp-1 agonist Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight

Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology

22.56

★★★★☆4.8 (126)

Diabetes Patients Also Struggle to Access GLP-1 Agonists

21.50

★★★★★4.9 (98)

Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review

22.75

★★★★★5.0 (157)

Retatrutide vs. Tirzepatide: The Next-Gen GLP-1 Showdown

29.33

★★★★★4.7 (84)

Tirzepatide for diabetes: on track to SURPASS current therapy

28.46

★★★★★4.9 (203)

𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿 𝗔𝗴𝗼𝗻𝗶𝘀𝘁𝘀 𝗼𝗻 𝗚𝗹𝘆𝗰𝗮𝘁𝗲𝗱 𝗛𝗲𝗺𝗼𝗴𝗹𝗼𝗯𝗶𝗻 𝗟𝗲𝘃𝗲𝗹𝘀 ⁣ ⁣ Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) receptor agonists have provided strong

24.65

★★★★★5.0 (176)

Tirzepatide vs Semaglutide for Weight Loss: Which is Better?

23.28

★★★★★4.8 (132)